0
0
Generated News

Biotech Company Pitches 'ETHzilla' Rebrand, $425M ETH Treasury

Nasdaq-listed 180 Life Sciences is pivoting to Ethereum after raising millions.
0
0
Jul 29, 20251 min read

Nasdaq-listed 180 Life Sciences has raised $425 million to create an Ethereum-focused treasury and is rebranding itself as ETHZilla, in partnership with institutional crypto investors and ecosystem leaders.

What’s the Scoop?

  • Funding Raise: The company secured $425 million in a private investment in public equity (PIPE), led by more than 60 institutional and crypto-native investors including Polychain, Electric Capital, and GSR.
  • Rebrand to ETHZilla: 180 Life Sciences will officially rebrand to ETHZilla Corporation upon closing around August 1.
  • ETH Acquisition Plan: The majority of capital will be used to purchase and vest its treasury in Ethereum, managed externally by Electric Capital.
  • On‑Chain Yield Strategy: ETHZilla will generate yield not only through staking but via a diversified on‑chain strategy—lending, liquidity provision, and structured protocols.
  • Ecosystem Governance: A DeFi Council made up of protocol leaders (e.g. founders of Lido, EigenLayer, Compound) through partner Etherealize will advise on deployment and strategy.https://www.theblock.co/post/364668/180-life-sciences-ethereum-treasury-ethzilla

Not financial or tax advice. This newsletter is strictly educational and is not investment advice or a solicitation to buy or sell any assets or to make any financial decisions. This newsletter is not tax advice. Talk to your accountant. Do your own research.

Disclosure. From time-to-time I may add links in this newsletter to products I use. I may receive commission if you make a purchase through one of these links. Additionally, the Bankless writers hold crypto assets. See our investment disclosures here.